No abstract

IMPORTANCE When making coverage determinations for off-label prescribing, Medicare Part D recognizes 2 compendia: the American Hospital Formulary Service (AHFS) Drug Information and the DRUGDEX Information System. Deficiencies in the accuracy and completeness of these compendia could result in coverage denials for necessary, effective, evidence-based treatments. OBJECTIVE To evaluate these compendia for dermatologic conditions, with a focus on less common conditions that often require systemic treatment.

No abstract

No abstract